EGFR and neoplasm: In this regard, a significant tumour suppression associated with a prolonged survival was shown in athymic nude mice bearing EGFR-positive human TNBCs treated with cetuximab-IR700 and exposed to NIR-light (50 J/cm2 on day 1 and 100 J/cm2 on day 2).